HOME >> BIOLOGY >> NEWS
Toward more effective paleolgenetic analysis

DNA preserved in bones undergoing fossilization deteriorates up to 50 times faster when stored in a museum than when the bones are buried in the ground. This has just been shown by a paleogenetics team led by Eva-Maria Geigl (Institut Jacques Mono / CNRS Paris). This study, which was published in the Proceedings of the US National Academy of Sciences 8 January 2007, shows that in order to improve the quality of paleogenetic analyses, archeological and paleontological remains should be treated like biological samples both during and after excavation. The findings show the need for a new methodology for the excavation, treatment and preservation of fossils. They also open up new prospects for paleogenetic research into freshly excavated fossils.

In paleogenetic research, it is essential to have well-preserved archeological material in order to obtain reliable results. At present, such research is only too rarely the result of close collaboration between the various disciplines involved: molecular biologists, archeologists, paleontologists and curators. Moreover, biologists mostly carry out such studies on samples stored in collections or in museums. However, there was no reason to suppose that the treatment carried out by fieldworkers (archeologists, paleontologists and curators), as well as storage conditions, were compatible with a paleogenetic approach. In fact, such analyses were often subject to a high failure rate, due partly to a lack of any ancient DNA detected by PCR , or to contamination by modern DNA.

An extensive study of around 250 fossil bones from 600 to 50 000 year old herbivores was carried out thanks to international cooperation between the Institut Jacques Monod at CNRS, the Museum of Natural Sciences in Madrid and a number of European, Turkish and Japanese paleontologists and archeologists. The work showed that mitochondrial DNA from freshly excavated, untreated fossil bones was amplified with a success rate of 46%. How
'"/>

Contact: Monica McCarthy
monica.mccarthy@cnrs-dir.fr
33-144-965-191
CNRS
17-Jan-2007


Page: 1 2 3

Related biology news :

1. Toward improved forms of a time-tested cholesterol-fighter
2. Dengue and other hemorrhagic fevers: Towards a first potential treatment
3. Towards predicting late-stage radiation toxicity
4. Toward a less expensive, more convenient treatment of Gauchers disease
5. Towards the mechanism of cell respiration
6. Towards a unified model of transcription termination
7. Towards a cheap and easy way to monitor HIV/AIDS
8. Towards targeted lung cancer treatment
9. Toward a better understanding of taste and smell impairments
10. Smokeless tobacco more effective than cigarettes for delivering dangerous carcinogens into the body
11. Developing a more effective vaccine for tuberculosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... FRANCISCO , Feb. 13, 2017  RSA ... centralized platform that is designed to enhance fraud ... latest release in the RSA Fraud & Risk ... enable organizations to leverage additional insights from internal ... tools to better protect their customers from targeted ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
(Date:3/24/2017)... March 24, 2017 Agenus Inc. (NASDAQ: AGEN), ... antibodies and cancer vaccines, today announced participation at the ...  Annual William Blair and Maidstone Life Sciences conference "Cancer ... in New York, NY . Agenus ... 29 at 9:40 am: Robert B. Stein , ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of the world,s ... systems, in terms of costs and resources. However, as the ... of innovative and efficient therapies that demonstrate higher chances of ... cancer treatments, a growing number of patients receiving immuno-oncology therapies ...
Breaking Biology Technology:
Cached News: